Aspek Neurobiologi dan Neuroimaging Bunuh Diri
DOI:
https://doi.org/10.55175/cdk.v48i8.110Keywords:
neurobiologi, neuroimaging, bunuh diriAbstract
Sejumlah 50% pelaku bunuh diri pernah melakukan percobaan bunuh diri sebelumnya. Sulitnya prediktor klinis dan tidak terdapatnya biomarker spesifik, menyulitkan prediksi perilaku bunuh diri. Perkembangan neurobiologi dan neuroimaging dapat memprediksi terjadinya upaya bunuh diri.
Fifty percent individuals who committed suicide have previously conducted suicide attempts. Rare clinical predictors and the absence of specific biomarkers, lead to difficulties in predicting suicidal behavior. Neurobiology and neuroimaging may predict the occurrence of suicide.
Downloads
References
World Health Organization. Global Health Observatory. Geneva: World Health Organization; 2018. who.int/gho/database/ en/. Accessed March 21, 2019.
Costanza A, D’Orta I, Perroud N, Burkhardt S, Malafosse A, Mangin P, et al. Neurobiology of suicide: Do biomarkers exist? Int J Legal Med. 2014; 128(1):73–82.
Van Heeringen K. Stress-diathesis model of suicidal behavior. In: Dwivedi Y, ed. The neurobiological basis of suicide. Boca Raton: CRC Press, 2012: 113–25.
Bachmann S. Epidemiology of suicide and the psychiatric perspective. Int J Environ Res Public Health. 2018;15(7):1–23.
Sokero TP, Melartin TK, Rytsala HJ, et al. Suicidal ideation and attempts among psychiatric patients with major depressive disorder. J Clin Psychiatr. 2003;64:1094–1100.
Valtonen H, Suominen K, Mantere O, et al. Suicidal ideation and attempts in bipolar I and II disorders. J Clin Psychiatry. 2005; 66:1456–62.
Malone KM, Haas GL, Sweeney JA, et al. Major depression and the risk of attempted suicide. J Affect Disord. 1995; 34:173–185.
Carballo JJ, Akamnonu CP, Oquendo MA. Neurobiology of suicidal behavior. An integration of biological and clinical findings. Arch Suicide Res. 2008; 12(2):93–110.
Ernst C, Mechawar N, Turecki G. Suicide neurobiology. Prog Neurobiol. 2009;89(4):315–33.
Pandey GN. Biological basis of suicide and suicidal behavior. Bipolar Disord. 2013;15 (5):524–41.
Van Heeringen K. The neurobiology of suicide and suicidality. Canad J Psychiatr. 2003; 48:292–300.
Jia Z, Huang X, Wu Q, et al. High-field magnetic resonance imaging of suicidality in patients with major depressive disorder. Am J Psychiatry. 2010; 167(11):1381–90.
Balcioglu YH, Kose S. Neural substrates of suicide and suicidal behaviour: from a neuroimaging perspective. Psychiatry Clin Psychopharmacol. 2018;0(0):1–15
Muehlenkamp J. Self-injurious behavior as a separate clinical syndrome. Am J Orthopsychiatr 2005;75(2):324-33
Klonsky E, May A, Glenn C. The relationship between nonsuicidal self-injury and attempted suicide: Converging evidence from four samples. J Abnormal Psychol. 2014;122 (1):231-37.
Jordans MJ, Kaufman A, Brenman NF, Adhikari RP, Luitel NP, Tol WA, Komproe I. Suicide in South Asia: A scoping review. BMC Psychiatr 2014;14;358.
Park S, Kim Y. Prevalence, correlates, and associated psychological problems of substance use in Korean adolescents. BMC Public Health 2016;16:79.
(Mann JJ, Apter A, Bertolode J, Beautrais A, Currier D, Haas A. Suicide Prevention trategies. A systematic review. JAMA 2005;294:2064-2074.)
Pandey GN. Biological basis of suicide and suicidal behavior. Bipolar Disord. 2013;15(5):524–41.
Sokero Petteri. Suicidal Ideation and Attempts Among Psychiatric Patients with Major Depressive Disorder. National Public Health Institute. 2006; 1; 24.
Bach H, Huang Y, Underwood MD, Dwork AJ, Mann JJ. Elevated Serotonin and 5-HIAA in the Brainstem and Lower Serotonin Turnover in the Prefrontal Cortex of Suicides NIH Public Access. 2015;68(3):127–30.
Menon, V., & Kattimani, S. (2015). Suicide and Serotonin: Making Sense of Evidence. Indian J Psychological Med. 2015; 37(3), 377–378.
Underwood MD. Kassir SA, Arango V. Neuron Density and Serotonin Receptor Binding in Prefrontal Cortex in Suicide. Int J Neuropsychopharmacol. 2012; 15(4); 435-447.
rango V, Underwood MD, Boldrini M, Tamir H, Kassir SA, Hsiung S et al. Serotonin 1A receptors, serotonin transporter binding and serotonin transporter mRNA expression in the brainstem of depressed suicide victims. Neuropsychopharmacol. 2001; 25:892-903
Mann JJ, Huang YY, Underwood MD, Kassir SA, Oppenheim S, Kelly TM et al. A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. Arch Gen Psychiatr. 2000; 57:729-738.
Roggenbach J, Oerlinghausen BM, Franke L. Suicidality, impulsivity and aggression—is there a link to 5HIAA concentration in the cerebrospinal fluid?. Psychiatr Res. 2002; 193–206.
Lindqvist D, Janelidze S, Erhardt S, Träskman-Bendz L, Engström G, Brundin L: CSF biomarkers in suicide attempters – a principal component analysis. Acta Psychiatr Scand 2011; 124 :52–61.
Currier D, Mann JJ. Stress, genes and the biology of suicidal behavior. Psychiatr Clin North Am. 2008;31(2):247–69.
Escribá PV, Ozaita A, García-Sevilla JA. Increased mRNA expression of alpha2A-adrenoceptors, serotonin receptors and mu-opioid receptors in the brains of suicide victims. Neuropsychopharmacol. 2004; 29:1512-1521.
Underwood MD, Mann JJ, Arango V. Serotonergic and noradrenergic neurobiology of alcoholic suicide. Alcohol Clin Exp Res. 2004; 28(suppl 5):57S-69S.
Sudol K, Mann JJ. Biomarkers of Suicide Attempt Behavior: Towards a Biological Model of Risk. Curr Psychiatr Rep. 2017; 19(6).
Rujescu D, Giegling I, Gietl A, et al. A functional single nucleotide polymorphism (V158M) in the COMT gene is associated with aggressive personality traits. Biol Psychiatr. 2003; 54:34– 39.
Pitchot W, Reggers J, Pinto E, Hansenne M, Fuchs S, Pirard S et al. Reduced dopaminergic activity in depressed suicides. Psychoneuroendocrinol. 2001; 26:331-335.
Ryding E, Ahnlide JA, Lindström M, Rosén I, Träskman-Bendz L. Regional brain serotonin and dopamine transporter binding capacity in suicide attempters relate to impulsiveness and mental energy. Psychiatr Res. 2006; 148:195-203
Lindström MB, Ryding E, Bosson P, Ahnlide JA, Rosén I, Träskman-Bendz L. Impulsivity related to brain serotonin transporter binding capacity in suicide attempters. Eur Neuropsychopharmacol. 2004; 14:295-300.
Brake WG, Zhang TY, Diorio J, Meaney MJ, Gratton A. Influence of early postnatal rearing conditions on mesocorticolimbic dopamine and behavioural responses to psychostimulants and stressors in adult rats. Eur J Neurosci. 2004; 19: 1863–74
Andersen SL, Teicher MH. Desperately driven and no brakes: developmental stress exposure and subsequent risk for substance abuse. Neurosci Biobehav Rev. 2009; 33: 516–524
Bruffaerts R, Demyttenaere K, Borges G, Haro JM, Chiu WT, Hwang I et al. Childhood adversities as risk factors for onset and persistence of suicidal behaviour. Br J Psychiatr. 2010; 197: 20–27
Pruessner JC, Champagne F, Meaney MJ, Dagher A. Dopamine release in response to a psychological stress in humans and its relationship to early life maternal care: a positron emission tomography study using [11C ]raclopride. J Neurosci. 2004; 24: 2825–2831.
Weaver IC, et al. Epigenetic programming by maternal behavior. Nat Neurosci. 2004; 7:847–54. [PubMed: 15220929]
Roth TL, Lubin FD, Funk AJ, Sweatt JD. Lasting epigenetic influence of early-life adversity on the BDNF gene. Biol Psychiatry. 2009; 65:760–9. [PubMed: 19150054]
Sequeira A, et al. Global brain gene expression analysis links glutamatergic and GABAergic alterations to suicide and major depression. PLoS One. 2009; 4:e6585.
Choudary PV, et al. Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression. Proc Natl Acad Sci U S A. 2005; 102:15653–8.
Zai CC, Zai GC, Tiwari AK, Manchia M, de Luca V, Shaikh SA, et al. Association study of GABRG2 polymorphisms with suicidal behaviour in schizophrenia patients with alcohol use disorder. Neuropsychobiol. 2014;69(3):154–8.
Bondy B, Buettner A, Zill P. Genetics of suicide. Mol Psychiatry. 2006; 11:336–351
Poulter MO, et al: GABA A receptor promoter hypermethylation in suicide brain: implications for the involvement of epigenetic processes. Biol Psychiatry 2008;64:645–652.
Bernstein HG, et al: Disruption of glutamate-glutamine-GABA cycle significantly impacts on suicidal behaviour: survey of the literature and own findings on glutamine synthetase. CNS Neurol Disord Drug Targets 2013;12: 900–913.
Lee R, Petty F, Coccaro EF: Cerebrospinal fluid GABA concentration: relationship with impulsivity and history of suicidal behavior, but not aggression, in human subjects. J Psychiatr Res 2009; 43:353–359.
Turecki G, Ernst C, Jollant F, Labonté B, Mechawar N. The neurodevelopmental origins of suicidal behavior. Trends Neurosci. 2012; 35:14–23
Ernst C, Mechawar N, Turecki G. Suicide neurobiology. Prog Neurobiol. 2009; 89:315–333
Raadsheer FC, et al. Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer’s disease and depression. Am J Psychiatr. 1995; 152:1372–6.
Raadsheer FC, Hoogendijk WJ, Stam FC, Tilders FJ, Swaab DF. Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinol. 1994; 60:436–44.
Wang SS, Kamphuis W, Huitinga I, Zhou JN, Swaab DF. Gene expression analysis in the human hypothalamus in depression by laser microdissection and real-time PCR: the presence of multiple receptor imbalances. Mol Psychiatr. 2008; 13:786–99. 741.
Nemeroff CB, et al. Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science. 1984; 226:1342–4.
Nemeroff CB, Owens MJ, Bissette G, Andorn AC, Stanley M. Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims. Arch Gen Psychiatr. 1988; 45:577–9.
McGowan PO, et al. Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat Neurosci. 2009; 12:342–8. [PubMed:19234457]
Lopez JF, et al. Localization and quantification of pro-opiomelanocortin mRNA and glucocorticoid receptor mRNA in pituitaries of suicide victims. Neuroendocrinol. 1992; 56:491–501.
Dumser T, Barocka A, Schubert E. Weight of adrenal glands may be increased in persons who commit suicide. Am J Forensic Med Pathol. 1998; 19:72–6. [PubMed: 9539397]
Szigethy E, Conwell Y, Forbes NT, Cox C, Caine ED. Adrenal weight and morphology in victims of completed suicide. Biol Psychiatry. 1994; 36:374–80. [PubMed: 7803598]
Merali Z, Du L, Hrdina P, Palkovits M, Faludi G, Poulter MO et al. Dysregulation in the suicide brain: mRNA expression of corticotropin releasing hormone receptors and GABA(A) receptor subunits in frontal cortical brain region. J Neurosci. 2004; 24:1478-1485.
Merali Z, Kent P, Du L, Hrdina P, Palkovits M, Faludi G et al. Corticotropin-releasing hormone, arginine vasopressin, gastrinreleasing peptide, and neuromedin B alterations in stress-relevant brain regions of suicides and control subjects. Biol Psychiatry. 2006; 59:594-602
Austin MC, Janosky JE, Murphy HA. Increased corticotropin-releasing hormone immunoreactivity in monoamine-containing pontine nuclei of depressed suicide men. Mol Psychiatry. 2003; 8:324-332.
Offord C. The neurobiology of suicide. The Scientist. 2020.
Aguilar EJ, Garcia-Marti G,Marti-Bonmati L, Lull JJ, Moratal D, Escarti MJ, et al. Left orbitofrontal and superior temporal gyrus structural changes associated to suicidal behavior in patients with schizophrenia. Prog Neuro-Psychopharmacol Biol Psychiatry. 2008;32(7):1673–6.
Benedetti F, Radaelli D, Poletti S, Locatelli C, Falini A, Colombo C, et al. Opposite effects of suicidality and lithium on gray matter volumes in bipolar depression. J Affect Disord. 2011;135(1–3): 139–47.
Hwang JP, Lee TW, Tsai SJ, Chen TJ, Yang CH, Lirng JF, et al. Cortical and subcortical abnormalities in late-onset depression with history of suicide attempts investigated with MRI and voxel-based morphometry. J Geriatr Psychiatry Neurol. 2010;23 (3):171–84.
Dombrovski AY, Siegle GJ, Szanto K, Clark L, Reynolds CF, Aizenstein H. The temptation of suicide: striatal gray matter, discounting of delayed rewards, and suicide attempts in late-life depression. Psychol Med. 2012;42(6):1203–15.
Soloff PH, Pruitt P, Sharma M, Radwan J,White R, Diwadkar VA. Structural brain abnormalities and suicidal behavior in borderline personality disorder. J Psychiatr Res. 2012;46(4):516–25.
Ahearn EP, Jamison KR, Steffens DC, Cassidy F, Provenzale JM, Lehman A, et al. MRI correlates of suicide attempt history in unipolar depression. Biol Psychiatry. 2001;50(4):266–70.
Ehrlich S, Breeze JL, Hesdorffer DC, Noam GG, Hong X, Alban RL, et al. White matter hyperintensities and their association with suicidality in depressed young adults. J Affect Disord. 2005;86(2–3):281–7.
Ehrlich S, Noam GG, Lyoo IK, Kwon BJ, Clark MA, Renshaw PF. White matter hyperintensities and their associations with suicidality in psychiatrically hospitalized children and adolescents. J Am Acad Child Adolesc Psychiatry. 2004;43(6):770–6.
Pompili M, Ehrlich S, De Pisa E, Mann JJ, Innamorati M, Cittadini A, et al. White matter hyperintensities and their associations with suicidality in patients with major affective disorders. ur Arch Psychiatry Clin Neurosci. 2007;257(8):494–9.
Pompili M, Innamorati M, Mann JJ, Oquendo MA, Lester D, Del Casale A, et al. Periventricular white matter hyperintensities as predictors of suicide attempts in bipolar disorders and unipolar depression. Prog Neuro-Psychopharmacol Biol Psychiatry. 2008;32(6):1501–7.
Jollant F, Lawrence NS, Giampietro V, BrammerMJ, FullanaMA, Drapier D, et al. Orbitofrontal cortex response to angry faces in men with histories of suicide attempts.Am J Psychiatry. 2008;165 (6):740–8.
Pan LA, Batezati-Alves SC, Almeida JR, Segreti A, Akkal D, Hassel S, et al. Dissociable patterns of neural activity during response inhibition in depressed adolescents with and without suicidal behavior. J Am Acad Child Adolesc Psychiatry. 2011;50(6): 602–11.
76 Cannon DM, Ichise M, Fromm SJ, Nugent AC, Rollis D, Gandhi SK, et al. Serotonin transporter binding in bipolar disorder assessed using [11C]DASB and positron emission tomography. Biol Psychiatry. 2006;60(3):207–17.
Miller JM, Hesselgrave N, Ogden RT, Sullivan GM, Oquendo MA, Mann JJ, et al. Positron emission tomography quantification of serotonin transporter in suicide attempters with major depressive disorder. Biol Psychiatry. 2013;74(4):287–95.
Yeh Y-W, Ho P-S, Chen C-Y, Kuo S-C, Liang C-S, Ma K-H, et al. Incongruent reduction of serotonin transporter associated with suicide attempts in patients with major depressive disorder: a positron emission tomography study with 4-[18F]-ADAM. Int J Neuropsychopharmacol. 2015;18(3):pyu065.
Nye JA, Purselle D, Plisson C, Voll RJ, Stehouwer JS, Votaw JR, et al. Decreased brainstem and putamen SERT binding potential in depressed suicide attempters using [11C]-zient PET imaging. Depress Anxiety. 2013;30(10):902–7.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Cermin Dunia Kedokteran
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
